Qube Research & Technologies Ltd

Position in ARVN — Arvinas, Inc.

CIK 1729829 LONDON, X0

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,231,813

+$494,482 QoQ

Shares Held

1,592,276

+32.5% QoQ

Ownership

2.44%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#10

of 201 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. ARVN ranks #39 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,231,813	1,592,276	+32.5%	Shares	Sole	2026-08-14
2026-03-31	$12,737,331	1,201,635	-9.3%	Shares	Sole	2026-05-15
2025-12-31	$15,711,416	1,324,740	-10.9%	Shares	Sole	2026-02-17
2025-09-30	$12,668,081	1,486,864	+154.8%	Shares	Sole	2025-11-14
2025-06-30	$4,294,758	583,527	+157.8%	Shares	Sole	2025-08-14
2025-03-31	$1,589,131	226,372	+197.1%	Shares	Sole	2025-05-15
2024-12-31	$1,460,715	76,198	-63.7%	Shares	Sole	2025-02-14
2024-09-30	$5,170,058	209,909	-30.0%	Shares	Sole	2024-11-14
2024-06-30	$7,979,211	299,745	+162.0%	Shares	Sole	2024-08-14
2024-03-31	$4,722,473	114,401	+1021.8%	Shares	Sole	2024-05-14
2023-12-31	$419,749	10,198	-29.3%	Shares	Sole	2024-02-13
2022-06-30	$607,106	14,424	+106.5%	Shares	Sole	2022-08-15
2021-03-31	$461,774	6,986	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.